The best indicator for Clorox (CLX)
We backtested 366 indicators across daily, weekly and hourly charts on real Clorox (CLX) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
SMC: Change of Character
On the weekly chart, this is the strongest risk-adjusted edge we found for Clorox (CLX) over ~53.5 years — beating buy-and-hold by 2.0% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Clorox (CLX) — trailing buy-and-hold by 2.1% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | SMC: Change of Character ✓ | Weekly | 10.0% | 0.58 | -43.1% | 75.0% | 20 | 2.0% |
| 2 | Stochastic RSI ✓ | Weekly | 6.9% | 0.56 | -36.0% | 69.3% | 88 | -1.1% |
| 3 | T3 15/60 Cross ✓ | Weekly | 8.3% | 0.54 | -42.4% | 66.7% | 18 | 0.3% |
| 4 | QQE ✓ | Weekly | 10.6% | 0.53 | -60.0% | 50.6% | 158 | 2.6% |
| 5 | SMA 20/50 Cross ✓ | Weekly | 8.3% | 0.51 | -44.3% | 55.2% | 29 | 0.3% |
| 6 | Trend Intensity Index ✓ | Weekly | 8.6% | 0.51 | -50.1% | 75.0% | 16 | 0.6% |
| 7 | Zero-Lag MACD ✓ | Weekly | 8.0% | 0.51 | -36.1% | 54.4% | 241 | 0.0% |
| 8 | TRIMA 200 Trend ✓ | Weekly | 8.5% | 0.51 | -61.3% | 47.1% | 17 | 0.5% |
| 9 | Markov Regime ✓ | Daily | 8.6% | 0.51 | -56.8% | 62.2% | 510 | 0.6% |
| 10 | McGinley 30 Trend ✓ | Weekly | 9.9% | 0.5 | -55.8% | 31.2% | 16 | 1.9% |
| 11 | McGinley 200 Trend ✓ | Weekly | 9.7% | 0.5 | -55.8% | 33.3% | 15 | 1.8% |
| 12 | VIDYA 200 Trend ✓ | Daily | 8.8% | 0.49 | -62.4% | 38.1% | 21 | 0.8% |
| 13 | McGinley 100 Trend ✓ | Daily | 9.8% | 0.49 | -60.2% | 25.0% | 44 | 1.9% |
| 14 | McGinley 200 Trend ✓ | Daily | 9.7% | 0.49 | -61.3% | 29.7% | 37 | 1.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Clorox (CLX), SMC: Change of Character on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.